0 NASDAQ Companies - February 20, 2019Marinus Pharmaceuticals to Present at the Leerink Healthcare ConferenceRead More
0 NASDAQ Companies - February 20, 2019Pluristem Enters into Collaboration with NASA to Study PLX Therapeutic Benefits in Space MissionsRead More
0 NASDAQ Companies - February 20, 2019ARCA Biopharma Announces FDA Agreement for a Single Phase 3 Clinical Trial to Support Approval for the First Genetically-Targeted Cardiovascular DrugRead More
0 NASDAQ Companies - February 20, 2019Primoris Services Corporation Announces Industrial Award Valued at $15 MillionRead More
0 NASDAQ Companies - February 20, 2019Harpoon Therapeutics to Present at SVB Leerink Global Healthcare ConferenceRead More
0 NASDAQ Companies - February 20, 2019Xeris Pharmaceuticals to Participate at SVB Leerink Global Healthcare ConferenceRead More
0 TSX Venture News - February 20, 2019Eguana Exercises Right to Acquire Limited Partnership UnitsRead More
0 NASDAQ Companies - February 20, 2019Clearside Biomedical Receives Notification of FDA Acceptance of NDA Filing for XIPERE™ (triamcinolone acetonide ophthalmic suspension) for Suprachoroidal Injection with PDUFA Date Set for October 19, 2019Read More
0 NYSE Companies - February 20, 2019Medtronic Announces U.S. Commercial Launch of Deep Brain Stimulation for Medically-Refractory EpilepsyRead More
0 NYSE Companies - February 20, 2019Five SolarWinds Leaders Recognized as 2019 CRN Channel ChiefsRead More
